SE7705851L - Forfarande for framstellning av en farmaceutisk komposition - Google Patents

Forfarande for framstellning av en farmaceutisk komposition

Info

Publication number
SE7705851L
SE7705851L SE7705851A SE7705851A SE7705851L SE 7705851 L SE7705851 L SE 7705851L SE 7705851 A SE7705851 A SE 7705851A SE 7705851 A SE7705851 A SE 7705851A SE 7705851 L SE7705851 L SE 7705851L
Authority
SE
Sweden
Prior art keywords
preparing
procedure
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
SE7705851A
Other languages
English (en)
Swedish (sv)
Inventor
T S Campbell
R W Keogh
B C Meakin
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of SE7705851L publication Critical patent/SE7705851L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7705851A 1976-05-21 1977-05-17 Forfarande for framstellning av en farmaceutisk komposition SE7705851L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB20986/76A GB1560489A (en) 1976-05-21 1976-05-21 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE7705851L true SE7705851L (sv) 1977-11-22

Family

ID=10155228

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7705851A SE7705851L (sv) 1976-05-21 1977-05-17 Forfarande for framstellning av en farmaceutisk komposition

Country Status (18)

Country Link
US (2) US4160844A (de)
JP (1) JPS5315428A (de)
AU (1) AU508191B2 (de)
BE (1) BE854691A (de)
CA (1) CA1085298A (de)
DE (1) DE2722916A1 (de)
DK (1) DK223377A (de)
FI (1) FI771582A (de)
FR (1) FR2361387A1 (de)
GB (1) GB1560489A (de)
IE (1) IE45200B1 (de)
IL (1) IL52103A (de)
LU (1) LU77365A1 (de)
NL (1) NL7705561A (de)
NO (1) NO771766L (de)
NZ (1) NZ184140A (de)
SE (1) SE7705851L (de)
ZA (1) ZA772990B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560489A (en) * 1976-05-21 1980-02-06 Fisons Ltd Pharmaceutical compositions
EP0008167A1 (de) * 1978-08-15 1980-02-20 FISONS plc Verbessertes Verfahren zur Herstellung von 6,7,8,9-Tetrahydro-5-hydroxy-4-oxo-10-propyl-4H-naphtho(2,3-b)pyran-2-carbonsäure
DK171089A (da) * 1988-04-11 1989-10-12 May & Baker Ltd Anvendelse af tetrazolderivater til fremstilling af laegemidler
KR100316571B1 (ko) * 1994-05-27 2002-05-30 파올로 비지, 엔리꼬 카쭐라니 타키키닌nk3수용체길항제로서퀴놀린유도체
ES2193405T3 (es) 1996-12-09 2003-11-01 Kao Corp Articulo impregnado de detergente.
JP2004519510A (ja) * 2001-03-30 2004-07-02 カラー アクセス，インコーポレイティド 化粧用組成物中のカプセル化染料
US7115287B2 (en) * 2005-03-03 2006-10-03 F.L.M., L.L.C. Topical medicament and method of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE817137C (de) * 1948-10-02 1951-10-15 Neuerburg Obsterei K G Walze zum Kristallisieren von Fluessigkeiten
US3864493A (en) * 1967-08-17 1975-02-04 Fisons Ltd Felixstowe Compositions and methods for the prevention of asthmatic symptoms
US3873714A (en) * 1971-07-14 1975-03-25 Syntex Inc Xanthone carboxylic acids and derivatives
US4133889A (en) * 1971-07-29 1979-01-09 Fisons, Ltd. 2(5-Tetrazolyl)chromones
GB1389227A (en) * 1971-09-16 1975-04-03 Fisons Ltd Chromone-2-carboxylic acid derivatives methods for their preparation and compositions containing them
JPS5118955B2 (de) * 1972-04-12 1976-06-14
GB1517153A (en) 1974-11-30 1978-07-12 Fisons Ltd Naphthopyran-and benzodipyran-2-carboxylic acids and derivatives thereof
GB1560489A (en) * 1976-05-21 1980-02-06 Fisons Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
ZA772990B (en) 1978-04-26
DK223377A (da) 1977-11-22
IE45200L (en) 1977-11-21
LU77365A1 (de) 1977-12-13
IL52103A (en) 1981-09-13
NL7705561A (nl) 1977-11-23
BE854691A (fr) 1977-11-16
US4269853A (en) 1981-05-26
AU508191B2 (en) 1980-03-13
NO771766L (no) 1977-11-22
IL52103A0 (en) 1977-07-31
IE45200B1 (en) 1982-07-14
AU2519677A (en) 1978-11-23
GB1560489A (en) 1980-02-06
FI771582A (de) 1977-11-22
JPS5315428A (en) 1978-02-13
FR2361387A1 (fr) 1978-03-10
US4160844A (en) 1979-07-10
FR2361387B1 (de) 1980-05-09
NZ184140A (en) 1978-06-20
CA1085298A (en) 1980-09-09
DE2722916A1 (de) 1977-12-01

Similar Documents

Publication Publication Date Title
SE431340B (sv) Forfarande for framstellning av en slagtalig propenpolymerkomposition
SE440791B (sv) Forfarande for upparbetning av lignitkol
DK153440C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE433804B (sv) Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
NO149897C (no) Fremgangsmaate til fremstilling av et kreppet papir
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
RO69885A (ro) Procedeu de preparare a l-piroglutamil-l-prolinamidei
SE7705851L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE417315B (sv) Forfarande for framstellning av n-(merkaptoacyl)-histidiner
FI773812A (fi) Farmaceutiska foereningar
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
SE7803456L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE7605751L (sv) Forfarande for framstellning av en bensotiazinforening
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
FI773813A (fi) Farmaceutiska foereningar
SE7705850L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE431751B (sv) Forfarande for framstellning av n-propargyl-piperonylamin hydroklorid